| Development of a model to predict healing of chronic wounds within 12 weeks SK Cho, S Mattke, H Gordon, M Sheridan, W Ennis Advances in wound care 9 (9), 516-524, 2020 | 49 | 2020 |
| Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: projecting the impact on the cost and wait times S Mattke, SK Cho, T Bittner, J Hlávka, M Hanson Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 46 | 2020 |
| Cost-effectiveness analysis of regorafenib and TAS-102 in refractory metastatic colorectal cancer in the United States SK Cho, JW Hay, A Barzi Clinical Colorectal Cancer 17 (4), e751-e761, 2018 | 34 | 2018 |
| Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States SK Cho, BS Manzoor, KR Sail, H Parisé, A Ravelo, S Shapouri, ... PharmacoEconomics, 1-11, 2020 | 20 | 2020 |
| Complications and hospital costs during hematopoietic stem cell transplantation for non-Hodgkin lymphoma in the United States SK Cho, J McCombs, N Punwani, J Lam Leukemia & lymphoma, 2019 | 20 | 2019 |
| Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment J Lam, H Jun, SK Cho, M Hanson, S Mattke Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021 | 10 | 2021 |
| How much value would a treatment for Alzheimer’s disease offer? cost-effectiveness thresholds for pricing a disease-modifying therapy H Jun, SK Cho, ER Aliyev, S Mattke, SC Suen Current Alzheimer Research 17 (9), 819-822, 2020 | 8 | 2020 |
| Switching pharmacies leads to gaps in medication possession in individuals treated with buprenorphine TJ Varisco, S Abughosh, H Chen, SK Cho, ML Fleming, D Ziedonis, ... Journal of the American Pharmacists Association 61 (5), 589-595, 2021 | 7 | 2021 |
| Outpatient wound clinics during COVID-19 maintained quality but served fewer patients SK Cho, S Mattke, M Sheridan, W Ennis Journal of the American Medical Directors Association 23 (4), 660-665. e5, 2022 | 6 | 2022 |
| Where do we go from here? A framework for using susceptible-infectious-recovered models for policy making in emerging infectious diseases RS Zawadzki, CL Gong, SK Cho, JE Schnitzer, NK Zawadzki, JW Hay, ... Value in Health 24 (7), 917-924, 2021 | 6 | 2021 |
| There is insufficient evidence to support a causal relationship between chili pepper consumption and mortality NK Zawadzki, CL Gong, SK Cho, JW Hay Journal of the American College of Cardiology 75 (15), 1864-1864, 2020 | 6 | 2020 |
| Association of wound healing with quality and continuity of care and sociodemographic characteristics. SK Cho, S Mattke, M Sheridan, W Ennis American Journal of Managed Care 28 (4), 2022 | 4 | 2022 |
| Is Korea prepared for an Alzheimer’s disease-modifying therapy? Assessing the Korean healthcare system infrastructure and the effect of blood-based biomarker tests H Jun, SK Cho, J Yoong, S Mattke Annals of geriatric medicine and research 25 (1), 33, 2021 | 3 | 2021 |
| Assessing the Preparedness of the Korean Healthcare System Infrastructure for an Alzheimer’s Treatment H Jun, SK Cho, J Yoong, S Mattke Center for Economic and Social Research, 2020 | 2* | 2020 |
| Association of cash payment with intensity of opioid prescriptions SK Cho, H Jun, TJ Varisco, J Lam, JA Romley, J Li, JD Thornton Journal of the American Pharmacists Association 62 (4), 1224-1231. e5, 2022 | 1 | 2022 |
| Substitution of generic drugs and biosimilars SK Cho, H Jun JAMA Internal Medicine 181 (4), 567-568, 2021 | 1 | 2021 |
| Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis V Tata, R Al Saadi, SK Cho, TJ Varisco, M Wanat, JD Thornton BMC Health Services Research 23 (1), 1185, 2023 | | 2023 |
| PYSICIAN PERSPECTIVES ON RISK MITIGATION STRATEGIES FOR PRESCRIBING OPIOIDS: A THEMATIC ANALYSIS OF A NATIONAL SURVEY V Tata, R Al Saadi, SK Cho, TJ Varisco, M Wanat, JD Thornton RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY 19 (3), 562-562, 2023 | | 2023 |
| Physician perspectives on risk mitigation strategies for prescribing opioids: A thematic analysis of a national survey V Tata, R Al Saadi, SK Cho, TJ Varisco, M Wanat, JD Thornton Research in Social and Administrative Pharmacy 19 (3), 3, 2023 | | 2023 |
| Value-Based Analysis of Therapies in Refractory Metastatic Colorectal Cancer in US SK Cho, T Bekaii-Saab, A Kavati, S Babajanyan, B Hocum, A Barzi Clinical colorectal cancer 21 (4), 277-284, 2022 | | 2022 |
Soeren MattkeResearch Professor of Economics, University of Southern CaliforniaVerified email at usc.edu
